Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,250,720 papers from all fields of science
Search
Sign In
Create Free Account
Pargyline Hydrochloride
Known as:
Hydrochloride, Pargyline
, Pargyline Hydrochloride [Chemical/Ingredient]
The hydrochloride salt form of pargyline, a monoamine oxidase (MAO) inhibitor with antidepressant activity. Pargyline selectively inhibits MAO type B…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Pargyline
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Mapping the amphetamine-evoked changes in [11C]raclopride binding in living rat using small animal PET: Modulation by MAO-inhibition
K. Pedersen
,
Mette Simonsen
,
+6 authors
P. Cumming
NeuroImage
2007
Corpus ID: 25555007
1999
1999
Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters.
F. A. Paczkowski
,
L. Bryan-Lluka
,
P. Pörzgen
,
M. Brüss
,
H. Bönisch
Journal of Pharmacology and Experimental…
1999
Corpus ID: 12016997
The aims of this study were to characterize the recently cloned rat norepinephrine transporter (NET) in more detail and in…
Expand
1994
1994
Alterations in dopamine metabolism by intraperitoneal ethanol in rats selected for high and low ethanol preference: a 3-methoxytyramine study.
A. Honkanen
,
S. J. Chrapusta
,
Farouk Karoum
,
Esa R. Korpi
Alcohol
1994
Corpus ID: 13572042
1981
1981
Postnatal development of dopaminergic neurons in the rabbit retina
D. M. Lam
,
S. Fung
,
Y. Kong
Journal of Neuroscience
1981
Corpus ID: 16394008
The emergence and maturation of dopaminergic neurons during postnatal development of the rabbit retina have been followed using…
Expand
Highly Cited
1968
Highly Cited
1968
Catecholamine turnover in normotensive and hypertensive man: effects of antiadrenergic drugs.
V. Dequattro
,
A. Sjoerdsma
Journal of Clinical Investigation
1968
Corpus ID: 27834370
Intravenous administration of tritium-labeled 3,4-dihydroxyphenylalanine (dopa) to human subjects resulted in the labeling of…
Expand
1967
1967
Pargyline hydrochloride poisoning in a child.
D. Lipkin
,
T. Kushnick
Journal of the American Medical Association (JAMA…
1967
Corpus ID: 32344422
PARGYLINE HYDROCHLORIDE (Eutonyl) is a nonhydrazine monamine oxidase inhibitor (MAOI) with a pharmacological property of lowering…
Expand
1966
1966
Induction of legal abortion by intra-uterine instillation of pargyline hydrochloride (eutonyl).
Z. Koren
,
Y. Pfeifer
,
F. Sulman
Journal of Reproduction and Fertility
1966
Corpus ID: 37273805
Summary. Injection of a single dose of 50 to 100 mg of the monoamine oxidase (mao) inhibitor pargyline HCl (Eutonyl\p=m-\Abbott…
Expand
1964
1964
DANGEROUS POTENTIATION OF MEPERIDINE HYDROCHLORIDE BY PARGYLINE HYDROCHLORIDE.
I. M. Vigran
Journal of the American Medical Association (JAMA…
1964
Corpus ID: 45230315
INTEREST IN the role of monoamine oxidase (MAO) inhibitors in the treatment of hypertensive disease has been stimulated by the…
Expand
Highly Cited
1964
Highly Cited
1964
ANGIOTHROMBOTIC PULMONARY HYPERTENSION IN ADDICTS. "BLUE VELVET" ADDICTION.
V. E. Wendt
,
H. Puro
,
J. Shapiro
,
W. Mathews
,
P. Wolf
Journal of the American Medical Association (JAMA…
1964
Corpus ID: 37214745
MAO is one of the enzymes involved in the metabolism of potent biogenic amines such as l-epinephrine, l-norepinephrine, serotonin…
Expand
1961
1961
Antihypertensive properties of pargyline hydrochloride. New non-hydrazine monoamine oxidase inhibitor compared with sulphonamide diuretics.
J. Bryant
,
S. Torosdag
,
+4 authors
R. B. Quan
Journal of the American Medical Association (JAMA…
1961
Corpus ID: 26594571
TAYLOR et al.1recently described a new, unusually potent, non-hydrazine, monoamine oxidase inhibitor: pargyline hydrochloride (MO…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE